IMPURITIES AVAILABLE FOR 'Lenvatinib Mesylate'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Lenvatinib Mesylate. Lenvatinib Mesylate is a multikinase inhibitor used in the treatment of advanced thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma. It works by inhibiting vascular endothelial growth factor receptors (VEGFR 1–3) and other kinases such as FGFR, PDGFR, RET, and KIT, thereby blocking tumor angiogenesis and cell proliferation. Lenvatinib is administered orally and demonstrates potent anti-tumor and anti-angiogenic activity across various cancers. It is often used alone or in combination with pembrolizumab for enhanced therapeutic effect. Common side effects include hypertension, fatigue, diarrhea, decreased appetite, and proteinuria. The drug undergoes hepatic metabolism, primarily via CYP3A4, and is excreted through feces and urine. Lenvatinib Mesylate has shown significant survival benefits in patients with advanced solid tumors resistant to conventional therapies. Buy high quality Buy high quality Abacavir from Omsynth Lifesciences. from Omsynth Lifesciences.